We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0M26 market cap is 278.58M. The company's latest EPS is USD -3.5542 and P/E is -9.53.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 18.37M | 29.39M | 38.16M | 6.03M | 4.76M |
Operating Income | -3.89M | 12.42M | 17.53M | -17.41M | -40.27M |
Net Income | -1.98M | 13.3M | 15.8M | -17.1M | -40.83M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 95.72M | 125.29M | 166.56M | 140.38M | 234.3M |
Total Liabilities | 51.74M | 38.86M | 24.69M | 16.37M | 145.58M |
Total Equity | 43.99M | 86.42M | 141.88M | 124.01M | 88.72M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -285k | 10.09M | 22.68M | -12.88M | -18.16M |
Investing | -19.3M | -209k | -26.5M | -20.22M | -711k |
Financing | 30.49M | 19.79M | 12.84M | -4.45M | 120.59M |
Market Cap | 278.58M |
Price to Earnings Ratio | -9.53 |
Price to Sales Ratio | 81.8 |
Price to Cash Ratio | 2.54 |
Price to Book Ratio | 4.39 |
Dividend Yield | - |
Shares Outstanding | 11.49M |
Average Volume (1 week) | 21 |
Average Volume (1 Month) | 17 |
52 Week Change | 0.00% |
52 Week High | 24.25 |
52 Week Low | 24.25 |
Spread (Intraday) | 0 (0%) |
Company Name | Xoma Corp |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.xoma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions